Travere Therapeutics: Eric Dube proposes $13M share sale

Three September transactions are identified as 10b5-1 sales for Eric Dube.

Rhea-AI Filing Summary

Travere Therapeutics, Inc. (TVTX) reported a proposed sale by Eric Dube, identified as a director and officer, of 243,735 common shares, with an approximate sale date of October 15, 2026 and an aggregate market value of $12,983,763.45. The shares are identified as coming from the exercise of stock options; Morgan Stanley Smith Barney LLC is named as broker.

Key Figures

Proposed sale: 243,735 common shares Aggregate market value: $12,983,763.45 Reported 10b5-1 sale: 108,493 common shares +2 more

5 metrics

Proposed sale 243,735 common shares Approximate sale date: October 15, 2026

Aggregate market value $12,983,763.45 Proposed sale of common shares

Reported 10b5-1 sale 108,493 common shares September 17, 2026; reported value $7,009,667.63

Reported 10b5-1 sale 195,841 common shares September 16, 2026; reported value $12,425,249.75

Reported 10b5-1 sale 95,666 common shares September 15, 2026; reported value $5,955,801.63

Key Terms

Rule 144, Rule 10b5-1, Exercise of Stock Options

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Rule 10b5-1 regulatory

"10b5-1 Sales for Eric Dube"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Exercise of Stock Options financial

"Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TVTX shares does Eric Dube plan to sell?

Eric Dube reported a proposed sale of 243,735 common shares, with an approximate sale date of October 15, 2026 and an aggregate market value of $12,983,763.45. The shares are identified as coming from the exercise of stock options.

What recent 10b5-1 sales did Eric Dube report for TVTX?

The reported sales were 108,493 shares on September 17, 2026, valued at $7,009,667.63; 195,841 shares on September 16, 2026, valued at $12,425,249.75; and 95,666 shares on September 15, 2026, valued at $5,955,801.63.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 04:41 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:40 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001763494
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive, Suite 300 San Diego CALIFORNIA 92130
Phone	8889697879
Name of Person for Whose Account the Securities are To Be Sold	ERIC DUBE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	243735	12983763.45	94261082	10/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/15/2026	Exercise of Stock Options	Issuer			243735	10/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERIC DUBE500 WALNUT ST 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	09/17/2026	108493	7009667.63
10b5-1 Sales for ERIC DUBE500 WALNUT ST 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	09/16/2026	195841	12425249.75
10b5-1 Sales for ERIC DUBE500 WALNUT ST 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	09/15/2026	95666	5955801.63

144: Remarks and Signature

Remarks
Date of Notice	10/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Eric Dube
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)